HengHong Technology, a holding company incorporated in the Cayman Islands, filed for a 2 million-share initial public offering, saying it intends to apply to list on the Nasdaq Capital Market under ...
West Pharmaceutical Services ... mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging ...
Heidelberg Pharma AG (FSE: HPHA), a clinical-stage biotech company developing innovative Antibody Drug Conjugates (ADCs), today announced that it will be presenting its latest ADC research results and ...
NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.
The company was formerly known as Receptor Technologies, Inc. and changed its name ACADIA Pharmaceuticals Inc. in 1997. ACADIA Pharmaceuticals Inc. was incorporated in 1993 and is headquartered in ...
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (“ Valneva ” or the “ Company ”), a specialty vaccine company, today announces that it has filed a prospectus supplement as part of the renewal of its ...
Reflect Scientific’s revenue for 2024 increased substantially compared to 2023, reflecting a rebound in customer demand, strategic product innovations, and strong market positioning. The company’s ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an IPO on Wednesday, April 2nd, IPO Scoop reports. The company plans to issue 2,700,000 shares at $7.50-$8.50 per share. The ...
Daily Wrap on MSN6d
Ireland's boomtown blues: Economic fears in a shifting landscapeIreland, dubbed the "Celtic Tiger" 30 years ago by one economist, now fears a slowdown triggered by American tariffs. The ...
In recent trading, shares of Vertex Pharmaceuticals, Inc. (Symbol: VRTX) have crossed above the average analyst 12-month target price of $505.52, changing hands for $513.76/share. When a stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results